Polymyositis is an acquired disorder in which necrosis of skeletal muscle fibres occurs with or without inflammatory cell infiltration; the skin may also be involved (dermatomyositis). In most cases steroid therapy in adequate dosage is followed by remission (Rose and Walton, 1966) . However, such improvement is neither invariable nor predictable. An initial response to this therapy may not be sustained or the condition may be refractory on relapse. Other cases are controlled only at the cost of unacceptable sideeffects. For these reasons, alternative therapy must occasionally be considered. Polymyositis probably has an immunological basis; evidence consistent with this view was recently summarized and was supported by the results of work carried out in this centre (Currie, Saunders, Knowles, and Brown, 1971) . The action of steroid derivatives may be immunosuppressive as well as anti-inflammatory (Schwartz, 1969) . American physicians have reported successful treatment with immunosuppressive agents in small numbers of cases (Malaviya, Many, and Schwartz, 1968; McFarlin and Griggs, 1968) . The drugs which they used were methotrexate and azathioprine. The theoretical and practical aspects of the use of immunosuppressive drugs in general have been fully discussed by Schwartz (1965, 1969) . Our own experience of treating polymyositis with such agents has been limited to a few cases and in these the regimes of treatment which were followed were somewhat arbitrary. Nevertheless, we feel that it is worth commenting on the place of immunosuppressive therapy in this disorder in the light of our recent experience.
CASE REPORTS
There were seven patients in whom immunosuppressive agents were used; the salient clinical details are given in the was given intermittently for eight weeks but caused intolerable gastrointestinal symptoms and no improvement in muscle power. Six months later the patient showed extreme wasting and weakness of all muscles and was confined to bed. The serum CK activity was 51-6 i.u./l. Blood lymphocytes were cytotoxic to both muscle and renal cultures and showed marked stimulation by muscle antigen . Methotrexate was given intravenously in an initial dose of 50 mg followed by 100 mg weekly. After a total of five injections there was slight subjective and objective improvement in muscle power. (Mastaglia and Currie, 1971) . A 62 year old woman presented with a history of proximal upper and lower limb weakness fornine months. Raynaud's phenomenon had occurred for many years. On examination there was severe wasting, weakness, and tenderness of proximal muscles. Biopsy of the left deltoid muscle revealed marked loss and necrosis of muscle fibres and widespread mononuclear cell infiltration. Electromyography of several muscles showed gross myopathic changes. The serum CK activity was 225 i.u./l. Immunoassay of the serum proteins suggested a polyclonal gammopathy. The Sia water test, , and a test for antinuclear factor were all positive. In vitro studies of peripheral blood lymphocytes showed cytotoxicity to muscle and to renal epithelial cultures and marked stimulation by muscle antigen . It was suggested that a malignant reticulosis might underlie the condition and treatment was commenced with prednisone (15 mg per day) and cyclophosphamide (100 mg per day). There was a rapid improvement in muscle power. Eight months later the patient was symptom free and all treatment had been withdrawn. Her blood lymphocytes retained their cytotoxicity, but the degree of stimulation by muscle antigen had fallen, though not to a normal level. The diagnosis was considered to be one of polymyositis occurring in association with an unidentified generalized disorder of connective tissue.
UNCOMPLICATED TYPE a POLYMYOSITIS CASE 7 (J.M., RVI No. 704643) A 64 year old man gave a history of weakness of proximal limb musculature for five years. Three years after the onset he was admitted for investigation. Electromyography of the right deltoid and quadriceps muscles gave findings suggestive of myopathy and a left deltoid muscle biopsy showed foci of necrosis and mononuclear cell infiltration. There was a partial response to prednisone 60 mg per day; subsequently any reduction below 20 mg per day was followed by clinical relapse with increased weakness. Congestive cardiac failure developed, persisting despite appropriate therapy including cardioversion. In August 1969 the patient had moderate weakness of deltoid, spinati, and iliopsoas muscles, with minimal weakness of other muscles. The serum CK activity was 633 i.u./l. Blood lymphocytes showed cytotoxicity for muscle cultures and stimulation by muscle antigen . Cyclophosphamide was given in an initial dose of 100 mg per day, increasing over a period of six weeks to 600 mg per day. Within one month there was subjective improvement and objective evidence of improved muscle power became apparent after two months. The prednisone was reduced to 5 mg per day during the next four months. The patient's exercise tolerance increased as the heart failure remitted. One year after cyclophosphamide was started, he was still taking 600 mg daily of this drug, the prednisone had been stopped and clinical improvement was continuing.
DISCUSSION
The safety of immunosuppressive drugs was firmly attested by Swanson and Schwartz (1967) and compares favourably with that of steroid derivatives. They reported benefit in several disorders; sideeffects such as serious leucopenia or infection were exceptional. Tests showed that there was a depression of immune responses but clinical effectiveness did not depend upon this. Schwartz (1969) listed mercaptopurine, methotrexate, and cyclophosphamide as the most effective agents for the induction of immunological tolerance. Mercaptopurine, of which azathioprine is a derivative, can selectively block the development of delayed hypersensitivity (Borel and Schwartz, 1964) . Methotrexate can not only do this but can also heal tuberculous ulcers (Friedman, 1964) . In experimental work, much larger doses of these drugs have been needed to suppress established hypersensitivity than to prevent its induction (Friedman, Buckler, and Baron, 1961; Gabrielsen and Good, 1967) . This fact is of relevance to the treatment of human 'autoimmune' disorders, in that the drugs may have to be given in high dosage for long periods. Nevertheless, low doses of 6-mercaptopurine were reported by Asai and Chikada (1963) to produce remissions in idiopathic thrombocytopenic purpura. The usual effectiveness of steroid therapy in these human conditions has restricted the use of immunosuppressive drugs to small numbers of cases in which steroids have been impracticable or unavailing. The potential of an individual case to respond to immunosuppressive agents may parallel its steroidresponsiveness (Goodman, Wolff, Carpenter, Anderson, and Brandiss, 1963) ; these drugs are unlikely to be tested if steroids are given with good effect. A point must be reached in the progression of any disorder when neither steroid nor immunosuppressive therapy can be expected to halt the disease process or to improve function (Swanson and Schwartz, 1967) .
The treatment of polymyositis by immunosuppressive drugs, as described in previous reports and in this paper, illustrates many of these comments. Malaviya et al. (1968) prednisone but the dose of this drug could not be reduced without deterioration and severe side-effects developed. The second case did not respond to ACTH during a relapse, while the third was not given steroid therapy. In two of these patients discontinuation of the azathioprine was followed by exacerbation.
The uniform benefit reported within weeks of commencing therapy in these seven cases previously reported prompted us to use immunosuppressive drugs in those of our patients in whom the condition was refractory to steroid therapy. Of the seven cases reported, only three (cases 4, 5, and 7) were under our immediate care, so that no consistent therapeutic regimen was employed. The variable results which have been obtained reflect the need for careful selection of cases and for adequate therapeutic trials. The most striking improvement occurred in case 6 whose condition responded to relatively small doses of prednisone and cyclophosphamide within three weeks. The initial dose of prednisone (15 mg) was only a quarter of that which Rose and Walton (1966) recommended if the drug were to be used alone; clearly it was much less likely to produce sideeffects. Equally the small dose of cyclophosphamide made the possibility of serious leucopenia a remote one. It is ironic that the drug regime in this patient was based on the erroneous assumption that the patient might be suffering from malignant disease as well as polymyositis. The rapid improvement in this case is even more noteworthy because polymyositis in association with connective-tissue disorders, type f of the Research Group on Neuromuscular Disorders (1968) , is less likely to respond to steroid therapy than is uncomplicated type o polymyositis (Rose and Walton, 1966) . Little or no improvement occurred in any of the other five patients with type 8 polymyositis (dermatomyositis, or polymyositis occurring in association with progressive systemic sclerosis or with rheumatoid arthritis). Indeed case 7, one of type of polymyositis, was the only other case in which improvement was remarkable. This man's condition differed from the subacute disorder which was present in all the seven treated cases previously reported in the literature. This patient had a chronic myopathy which was only partly responsive to a dose of prednisone which had been sufficient to induce cardiac failure. The myositis improved with cyclophosphamide and the prednisone was later stopped without relapse. In our two patients who improved, long-term immunosuppressive therapy was uncomplicated without obvious side-effects. In cases 4 and 5 the improvement was temporary and equivocal; in them the drugs were used as a last resort. In each, muscular atrophy was extreme and there were other factors which made prolonged immunosuppressive therapy impracticable. Systemic sclerosis is notably unresponsive to steroid therapy (Winkelmann, 1961) as in our case 3. In this patient, the therapeutic trial of cyclophosphamide was probably inadequate and this drug produced no improvement either; there could possibly have been a response to more prolonged treatment with higher doses. In the second case of systemic sclerosis (case 4) methotrexate produced slight and insignificant improvement.
Based (Swanson and Schwartz, 1967 (Montgomerie, Becroft, Croxson, Doak, and North, 1969) , and possibly to neoplasia (Burnet, 1967) . In discussing the problem of relapses in polymyositis, Rose and Walton (1966) recommended that steroid therapy should be given for at least two years. If a combination of steroid and immunosuppressive therapy has been given initially, as in case 1, it would seem reasonable to phase out the immunosuppressive drug after a year, while continuing a small dose of prednisone. When immunosuppressive therapy has been given alone, gradual withdrawal could be tried at the end of a year.
6. With two types of therapy, steroid and immunosuppressive agents, both ofproven efficacy and safety, the exhibition of anti-lymphocytic antiserum in polymyositis would seem to be justified only in the most exceptional circumstances.
The implications of responsiveness to either steroid or immunosuppressive therapy have been discussed by Schwartz (1969) . He and his co-workers (Malaviya et al., 1968) (Perlmann and Holm, 1970) . However, the results clearly indicate that there is a disturbance ofimmunological processes in polymyositis and suggest that sensitized lymphocytes are possibly instrumental in producing the disorder. In four cases the in vitro studies were repeated after immunosuppressive therapy; there was a reduction in the degree of lymphocyte stimulation but the cytotoxic potential of the cells persisted. These findings are in some respects comparable with those of Swanson and Schwartz (1967) who found that the depression of immune responses was variable and that it was not always consistent with the clinical response to therapy. The efficacy of immunosuppressive drugs in polymyositis is further evidence that any role which viruses may have in the pathogenesis of the condition is an indirect one. The occasional finding on electron microscopy of intracellular virus-like particles in muscle biopsy specimens from patients with the condition (Chou, 1968; Mastaglia and Walton, 1970) could be taken to suggest that it is a direct viral myositis. However, it is more likely that viruses are merely one of several agents which may alter the antigenic potential of muscle cells and precipitate a hypersensitivity reaction against these (Isacson, 1967) .
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